Clinical Trials | March 05, 2026
The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Duvakitug was well tolerated and safety was consistent with the induction study
Achondroplasia is a genetic condition driven by FGFR3 that affects more than stature alone
PiNACLE is a head-to-head study comparing its next-generation CAR T-cell therapy against established therapies liso-cel and axi-cel in patients with relapsed or refractory large B-cell lymphoma
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
